But, then, at 4pm on Christmas Eve, after 211 days in hospital, their wish was granted. Elsie was well enough to go home. It was the moment Debi and Chris had hardly dared to hope for. But the impact of Elsie’s early birth did not end there.
For years Elsie needed 24-hour oxygen support and had to be tube-fed. Today, Elsie is walking and talking – precious milestones that Debi and Chris were once told she might never reach – but her health remains fragile. Since coming home she has been hospitalised eight times for viruses and respiratory infections due to adrenal insufficiency which makes her vulnerable to illness. She also still faces challenges with her development.
"Even something as ordinary as taking her to meet Father Christmas was simply too risky because of the germs she could be exposed to," explains Chris.
No baby should have to begin life with such an enormous struggle, not to mention the ongoing challenges that follow.
Each year, around 55,000 babies are born prematurely in the UK – and sadly, more than 1,000 babies die each year after being born too soon.
Action Medical Research is supporting a research team at University College London who are developing an innovative antimicrobial therapy that aims to boost the body’s natural defences against infection. If successful, this could ultimately help prevent preterm labour in women at high risk of giving birth too soon – improving survival and quality of life for their babies.
Speaking about the importance of research into premature birth, Chris says: “Having come through this, it’s now important to us to do anything we can do to prevent this happening to others in future. That’s why research to prevent premature birth means so much to us. It plays a big part in the outcomes for those involved.”
Research gives us hope that, one day, fewer babies like our Elsie will have to start life fighting to survive simply because they were born too soon.
